A Multiple Ascending Dose Study of COR388

NCT03418688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: COR388
DRUG: Placebo

Sponsor

Cortexyme Inc.